Article
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
Journal of medicinal chemistry - 24 Mar 2005
Surleraux Dominique L N G, Tahri Abdellah, Verschueren Wim G, Pille Geert M E, de Kock Herman A, Jonckers Tim H M, Peeters Anik, De Meyer Sandra, Azijn Hilde, Pauwels Rudi, de Bethune Marie-Pierre, King Nancy M, Prabu-Jeyabalan Moses, Schiffer Celia A, Wigerinck Piet B T P
Abstract excerpt
The screening of known HIV-1 protease inhibitors against a panel of multi-drug-resistant viruses revealed the potent activity of TMC126 on drug-resistant mutants. In comparison to amprenavir, the improved affinity of TMC126 is largely the result of one extra hydrogen bond to the backbone of the protein in the P2 pocket. Modification of the substitution pattern on the phenylsulfonamide P2' substituent of TMC126...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
